Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Christopher Soo

Dr Christopher Soo

ADHD in Children – Practical Advice and Update for GPs

Prof Rod Baber

Prof Rod Baber

Oral vs Transdermal MHT – Which Option for Who?

Prof Jason Ong

Prof Jason Ong

The Mpox Emergency – What You Need to Know

Dr Janet Green

Dr Janet Green

Infant and Specialty Formula – What’s in Them and Why

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof William Ledger

expert

Prof William Ledger

Gynaecologist; Royal Hospital for Women, UNSW

Date published: 8 August 2023